Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Scope of the Report:
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.
Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.
The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.
Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%
Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.
Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Heparin is expected to grow at a CAGR of roughly 3.3% over the next five years, will reach 1200 million US$ in 2024, from 990 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Heparin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Hepalink
Changshan Pharm
Qianhong Bio-pharma
Opocrin
Pfizer
Aspen Oss
King-friend Biochemical Pharmaceutical
Bioibérica
Dongcheng Biochemicals
Jiulong Biochemicals
Tiandong
Xinbai
Yino Pharma Limited
Deebio
Request For Sample Report @ https://www.wiseguyreports.com/sample-request/3719720-global-heparin-market-2019-by-manufacturers-regions-type
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Heparin Sodium
Heparin Calcium
Other
Market Segment by Applications, can be divided into
UFH
LMWH
Complete Report Details @ https://www.wiseguyreports.com/reports/3719720-global-heparin-market-2019-by-manufacturers-regions-type
Table Of Contents:
1 Market Overview
1.1 Heparin Introduction
1.2 Market Analysis by Type
1.2.1 Heparin Sodium
1.2.2 Heparin Calcium
1.2.3 Other
1.3 Market Analysis by Applications
1.3.1 UFH
1.3.2 LMWH
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Hepalink
2.1.1 Business Overview
2.1.2 Heparin Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Hepalink Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Changshan Pharm
2.2.1 Business Overview
2.2.2 Heparin Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Changshan Pharm Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Qianhong Bio-pharma
2.3.1 Business Overview
2.3.2 Heparin Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Qianhong Bio-pharma Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Opocrin
2.4.1 Business Overview
2.4.2 Heparin Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Opocrin Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Pfizer
2.5.1 Business Overview
2.5.2 Heparin Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pfizer Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Aspen Oss
2.6.1 Business Overview
2.6.2 Heparin Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aspen Oss Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 King-friend Biochemical Pharmaceutical
2.7.1 Business Overview
2.7.2 Heparin Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 King-friend Biochemical Pharmaceutical Heparin Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Continued…….
Media Contact
Company Name: Wiseguyreports.com
Contact Person: Norah Trent
Email: Send Email
Phone: +1 646 845 9349, +44 208 133 9349
City: Pune
State: Maharashtra
Country: India
Website: www.wiseguyreports.com